PropertyValue
?:abstract
  • The need to address COVID-19 is placing huge demands on biomedical research and regulatory processes. Under pressure, it is essential to uphold high bioethical principles and rigorous standards for the development and approval of medicines.
?:doi
  • 10.1038/s43018-020-00123-2
?:doi
?:journal
  • Nat_Cancer
?:license
  • no-cc
?:pmc_json_files
  • document_parses/pmc_json/PMC7485203.xml.json
?:pmcid
?:pmid
?:pmid
  • 32935085.0
?:publication_isRelatedTo_Disease
?:source
  • Medline; PMC
?:title
  • Don’t shortchange public trust in science
?:type
?:year
  • 2020-09-11

Metadata

Anon_0  
expand all